ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Number Of Uninsured To Increase, Report Finds.

October 12, 2001

Cullen To Leave NCI, Will Become Director Of AMC Cancer Center; Nixon May Join ACS

April 14, 1989

OHSU Get $500 Million Pledge; Funds to be Matched in Two Years

September 27, 2013

NCI Plans Briefing Oct. 8 In St. Louis for SPORE Applicants

August 23, 1991

House panel examines use of grant funds.

September 23, 2005

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009